Characterization of bradykinin B2 receptor antagonists in human and rat urinary bladder

European Journal of Pharmacology

Volumn 388, Issue 2, 2000, Pages 177-182

  Meini, Stefania ^a   Patacchini, Riccardo ^a   Giuliani, Sandro ^a   Lazzeri, Massimo ^b   Turini, Damiano ^b   Maggi, Carlo Alberto ^a   Lecci, Alessandro ^a  

^a Pharmacology Department   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Bradykinin B2 receptor; Bradykinin receptor antagonist; Cystitis; human; MEN 11270; Rat; Urinary bladder

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; MEN 11270; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG POTENCY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION;

AGED; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; ANIMALS; BRADYKININ; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OLIGOPEPTIDES; PEPTIDES, CYCLIC; QUINOLINES; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; URETHANE; URINARY BLADDER;

EID: 0033979035     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00882-1     Document Type: Article

References (33)

1. Ahluwalia A., Maggi C.A., Santicioli P., Lecci A., Giuliani S. Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br. J. Pharmacol. 111:1994;1017-1022.
2. Altamura M., Meini S., Quartara L., Maggi C.A. Nonpeptide antagonists for kinin receptors. Regul. Pept. 80:1999;13-26.
3. Andersson K.-E. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev. 45:1993;253-308.
4. Andersson K.-E., Hedlund H., Stahl M. Contractions induced by angiotensin I, angiotensin II and bradykinin in isolated muscle from human detrusor. Acta Physiol. Scand. 145:1992;253-259.
5. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14:1959;48-58.
6. Asano M., Inamura N., Hatori C., Sawai H., Fujiwara T., Katayama A., Kayakiri H., Satoh S., Abe Y., Inoue T., Sawada Y., Nakahara K., Oku T., Okuhara M. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657. Br. J. Pharmacol. 120:1997;617-624.
7. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1992;1-80.
8. Eggerickx D., Raspe E., Bertrand D., Vassart G., Parmentier M. Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor gene. Biochem. Biophys. Res. Commun. 187:1992;1306-1313.
9. Giuliani S., Santicioli P., Lippe I.Th., Lecci A., Maggi C.A. Effect of bradykinin and tachykinin receptor antagonist on xylene-induced cystitis in rats. J. Urol. 150:1993;1014-1017.
10. Griesbacher T. Effects of the non-peptide bradykinin antagonist, FR173657, in experimental models of acute pancreatitis and cystitis in rats. Br. J. Pharmacol. 122:1997;352.
11. 2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception. Br. J. Pharmacol. 124:1998;1328-1334.
12. 2 receptor antagonists. Br. J. Pharmacol. 126:1999;197-204.
13. Hess J.F., Borkowski J.A., Young G.S., Strader C.D., Ransom R.W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184:1992;260-268.
14. 2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia. Pain. 75:1998;169-176.
15. Kenakin T.P. Competitive antagonism. In Pharmacologic Analysis of Drug-Receptor Interaction. 3rd edn. 1997;331-373 Lippincott-Raven Press Publishers, Philadelphia, PA.
16. Lecci A., Giuliani S., Meini S., Maggi C.A. Pharmacological analysis of the local and reflex responses to bradykinin on the rat urinary bladder motility in vivo. Br. J. Pharmacol. 114:1995;708-714.
17. Lung C.-C., Jagels M.A., Daffern P.J., Tan E.M., Zuraw B.L. Induction of human B2 bradykinin receptor mRNA and membrane receptors by IFNγ Immunopharmacology. 39:1998;243-253.
18. Maggi C.A. Bradykinin as an inflammatory mediator in the urinary tract. Farmer S. The Kinin System. 1997;235-247 Academic Press, London.
19. Maggi C.A., Parlani M., Astolfi M., Santicioli P., Rovero P., Abelli L., Somma V., Giuliani S., Regoli D., Patacchini R., Meli A. Neurokinin receptors in the rat lower urinary tract. J. Pharmacol. Exp. Ther. 246:1988;308-315.
20. Maggi C.A., Patacchini R., Santicioli P., Geppetti P., Cecconi R., Giuliani S., Meli A. Multiple mechanisms in the motor responses of the guinea-pig isolated urinary bladder. Br. J. Pharmacol. 98:1989;619-629.
21. Maggi C.A., Santicioli P., Del Bianco E., Lecci A., Giuliani S. Evidence for the involvement of bradykinin in chemically-evoked cystitis in anaesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;432-437.
22. Maggi C.A., Santicioli P., Patacchini R., Cellerini M., Turini D., Barbanti G., Beneforti D., Rovero P., Meli A. Contractile response of the human isolated urinary bladder to neurokinins: involvement of NK2 receptors. Eur. J. Pharmacol. 145:1988;335-340.
23. Majima M., Kawashima N., Hiroshi I., Katori M. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 121:1997;723-730.
24. 1 receptors for kinins. Pharmacol. Rev. 50:1998;357-386.
25. Meini S., Lecci A., Cucchi P., Catalioto R.-M., Criscuoli M., Maggi C.A. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists. J. Pharmacol. Exp. Ther. 287:1998;137-143.
26. 2 kinin receptor. J. Pharmacol. Exp. Ther. 289:1999;1250-1256.
27. Menke J.G., Borkowski J.A., Bierilo K.K., Macneil T., Derrick A.W., Schneck K.A., Ransom R.W., Strader C.D., Linemeyer D.L., Hess J.F. Expression cloning of a human B1 bradykinin receptor. J. Biochem. Chem. 269:1994;21583-21586.
28. Paquet J.-L., Luccarini J.-M., Fouchet C., Defrêne E., Loillier B., Robert C., Bélichard P., Cremers B., Pruneau D. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses. Br. J. Pharmacol. 126:1999;1083-1090.
29. Rosamilla A., Clements J.A., Dwyer P.L., Kende M., Campbell D.J. Activation of the kallikrein kinin system in interstitial cystitis. J. Urol. 162:1999;129-134.
30. 2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells. Mol. Phamacol. 53:1998;1009-1015.
31. Watanabe M., Yoshihara S., Abe T., Oyama M., Arisaka O. Effects of the orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma extravasation in guinea pig airways. Eur. J. Pharmacol. 367:1999;373-378.
32. Wirth K., Hock F.J., Albus U., Linz W., Alpermann H.G., Anagnastopulos H., Henke S., Breiphol G., König W., Knolle J., Schölkens B. Icatibant, a new potent and long-acting bradykinin antagonist: in vivo studies. Br. J. Pharmacol. 102:1991;774-777.
33. Zuraw B.L., Sugimoto S., Parsons C.L., Hugli T., Lotz M., Koziol J. Activation of urinary kallikrein in patients with interstitial cystitis. J. Urol. 152:1994;874-878.